How to buy bluebird bio (BLUE) stock

bluebird bio, Inc is a biotechnology business based in the US. bluebird bio shares (BLUE) are listed on the NASDAQ and all prices are listed in US Dollars. bluebird bio employs 1,201 staff and has a trailing 12-month revenue of around 0.00.

bluebird bio stock price (NASDAQ: BLUE)

Use our graph to track the performance of BLUE stocks over time.

bluebird bio shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$31.12
52-week range	$24.24 - $68.39
50-day moving average	$31.08
200-day moving average	$33.73
Wall St. target price	$46.93
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-12.00

Buy bluebird bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy bluebird bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of bluebird bio, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

bluebird bio price performance over time

Historical closes compared with the close of $31.12 from 2021-05-28

1 week (2021-07-17)	N/A
1 month (2021-06-28)	-0.16%
3 months (2021-04-28)	2.40%
6 months (2021-01-24)	N/A

1 year (2020-07-24)	N/A
2 years (2019-07-24)	N/A
3 years (2018-07-24)	N/A
5 years (2016-07-24)	N/A

Is bluebird bio under- or over-valued?

Valuing bluebird bio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of bluebird bio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

bluebird bio's PEG ratio

bluebird bio's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.32. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into bluebird bio's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

bluebird bio financials

Revenue TTM	$241.7 million
Gross profit TTM	$-342,618,000
Return on assets TTM	-25.81%
Return on equity TTM	-53.59%
Profit margin	-257.34%
Book value	$17.80
Market capitalisation	$1.8 billion

TTM: trailing 12 months

Shorting bluebird bio shares

There are currently 6.3 million bluebird bio shares held short by investors – that's known as bluebird bio's "short interest". This figure is 18.4% up from 5.3 million last month.

There are a few different ways that this level of interest in shorting bluebird bio shares can be evaluated.

bluebird bio's "short interest ratio" (SIR)

bluebird bio's "short interest ratio" (SIR) is the quantity of bluebird bio shares currently shorted divided by the average quantity of bluebird bio shares traded daily (recently around 1.9 million). bluebird bio's SIR currently stands at 3.32. In other words for every 100,000 bluebird bio shares traded daily on the market, roughly 3320 shares are currently held short.

However bluebird bio's short interest can also be evaluated against the total number of bluebird bio shares, or, against the total number of tradable bluebird bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case bluebird bio's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 bluebird bio shares in existence, roughly 90 shares are currently held short) or 0.0949% of the tradable shares (for every 100,000 tradable bluebird bio shares, roughly 95 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against bluebird bio.

Find out more about how you can short bluebird bio stock.

bluebird bio share dividends

We're not expecting bluebird bio to pay a dividend over the next 12 months.

bluebird bio share price volatility

Over the last 12 months, bluebird bio's shares have ranged in value from as little as $24.24 up to $68.39. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while bluebird bio's is 1.7394. This would suggest that bluebird bio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

bluebird bio overview

bluebird bio, Inc. , a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; LentiGlobin for the treatment of sickle cell disease; and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's product candidates in oncology include Idecabtagene vicleucel and bb21217, which are chimeric antigen receptor T (CAR T) cell product candidates for the treatment of multiple myeloma. It has collaboration and license agreements with Bristol-Myers Squibb, Regeneron Pharmaceuticals, Inc. , Novartis Pharma AG, Orchard Therapeutics Limited, Medigene AG, Novo Nordisk A/S, Forty Seven, Inc. , Gritstone Oncology, Inc.

Frequently asked questions

What percentage of bluebird bio is owned by insiders or institutions?
Currently 0.894% of bluebird bio shares are held by insiders and 79.665% by institutions. How many people work for bluebird bio?
Latest data suggests 1,201 work at bluebird bio. When does the fiscal year end for bluebird bio?
bluebird bio's fiscal year ends in December. Where is bluebird bio based?
bluebird bio's address is: 60 Binney Street, Cambridge, MA, United States, 02142 What is bluebird bio's ISIN number?
bluebird bio's international securities identification number is: US09609G1004 What is bluebird bio's CUSIP number?
bluebird bio's Committee on Uniform Securities Identification Procedures number is: 09609G100